GLITOS 45 pioglitazone (as hydrochloride) 45mg tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

pioglitazone hydrochloride, Quantity: 49.608 mg (Equivalent: pioglitazone, Qty 45 mg)

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Pioglitazone hydrochloride

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: hyprolose; magnesium stearate; lactose monohydrate; carmellose calcium

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

50 tablets, 7 tablets, 28 tablets, 98 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Treatment of type 2 diabetes inadequately controlled by diet and exercise: ? As monotherapy ? As dual therapy to improve glycaemic control - In combination with metformin or sulfonylurea - In combination with insulin ? As triple therapy to improve glycaemic control - In combination with metformin and sulfonylurea

Sommarju tal-prodott:

Visual Identification: White to off white, round, flat faced beveled edge uncoated tablets debossed with'T' shape break-line on both sides; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2011-10-26